A micro-metabolic rewiring assay for assessing hypoxia-associated cancer metabolic heterogeneity.
Ontology highlight
ABSTRACT: Cancer metabolism plays an essential role in therapeutic resistance, where significant inter- and intra-tumoral heterogeneity exists. Hypoxia is a prominent driver of metabolic rewiring behaviors and drug responses. Recapitulating the hypoxic landscape in the tumor microenvironment thus offers unique insights into heterogeneity in metabolic rewiring and therapeutic responses, to inform better treatment strategies. There remains a lack of scalable tools that can readily interface with imaging platforms and resolve the heterogeneous behaviors in hypoxia-associated metabolic rewiring. Here we present a micro-metabolic rewiring (μMeRe) assay that provides the scalability and resolution needed to characterize the metabolic rewiring behaviors of different cancer cells in the context of hypoxic s
SUBMITTER: Oh JM
PROVIDER: S-EPMC11910375 | biostudies-literature | 2025 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA